Morphochem announces determination of the X-ray structure of Endothelin Converting Enzyme (ECE-1) complexed with Phosphoramidon
Morphochem AG has announced that they have successfully achieved an important milestone in their research collaboration with Solvay Pharmaceuticals using Morphochem's structural biology tools to support their Endothelin-Converting Enzyme inhibitor program.
Morphochem applied its protein expression, purification, crystallization and structure determination capabilities to generate biostructural information for further optimization of inhibitor compounds against Endothelin-Converting Enzyme.
Commenting on the collaboration, Glenn E. Dale, Head of Biological Sciences at Morphochem said: "We are delighted that Morphochem could rapidly and successfully determine the three-dimensional structure of ECE-1 complexed with phosphoramidon, thereby providing the necessary tools to Solvay for this very important target."
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Studies confirm proof-of-principle for Geron's Human Embryonic Stem Cell (HESC) derived hepatocytes

How the use of chemicals and biodiversity loss are connected
Implantable device cuts obstructive sleep apnea symptoms - Offers promise for patients unable to tolerate CPAP

Little helpers for metal extraction - Using bacteria for electronic waste recycling

'Tricking' bacteria into hydroxylating benzene
Intel and Fred Hutchinson Cancer Research Center to Explore the Use of Nanotechnology Tools for Early Disease Detection - The Intel Raman Bioanalyzer System(TM) to Help Researchers Understand the Molecular Differences Between Healthy Cells and Diseased Cells for Better Diagnostic Methods
Bronchiolitis_obliterans_organizing_pneumonia
